Metconazole

CAS: 125116-23-6

Ref. 3D-FM46463

Información del producto

• Nombre: Metconazole
• Sinónimos: 5-[(4-Chlorophenyl)methyl]-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol(1RS,5RS,1RS,5SR)-5-(4-chlorobenzyl)-2,2-dimeth yl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol, (1Rs,5Rs, 1RS,5RS)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol, 5-((4-chlorophenyl)methyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol, 5-(4-Chlorophenylmethyl)-2,2-Dimethyl-1-(1H-1,2,4-Triazol-1-Ylmethyl)Cyclopentanol, 5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol, Caramba, Cyclopentanol, 5-(4-chlorophenyl)methyl-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)-, Dimetconazole, Metaconazole, Metconazole (Bsi,Pa Iso), Metlock, Metlock, 5-[(4-chlorophenyl)methyl]-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)-, Quash, Sunorg Pro, Tourney, Work-up Flowable
• CAS: 125116-23-6

Descripción

Metconazole is a triazole antifungal drug with systemic activity. It inhibits the synthesis of ergosterol and other sterols, which are essential for fungal cell membranes. Metconazole has been shown to have synergistic effects when combined with other fungicides in a lc-ms/ms method for analysis of terminal residues in wheat. The most frequent adverse effect of metconazole treatment is photosensitivity. Metconazole has been studied extensively for its potential carcinogenic properties, but there is no conclusive evidence that it causes cancer in humans or animals. There have been conflicting results from studies on the carcinogenic potential of metconazole.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 319.83 g/mol
• Fórmula: C₁₇H₂₂ClN₃O
• Pureza: Min. 95%
• InChI: InChI=1S/C17H22ClN3O/c1-16(2)8-7-14(9-13-3-5-15(18)6-4-13)17(16,22)10-21-12-19-11-20-21/h3-6,11-12,14,22H,7-10H2,1-2H3
• Clave InChI: InChIKey=XWPZUHJBOLQNMN-UHFFFAOYSA-N
• SMILES: CC1(C)CCC(Cc2ccc(Cl)cc2)C1(O)Cn1cncn1